| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.33 | 4e-10 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.3 | 3e-07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.1 | 0.1 |